Unicycive Theraputics, Inc
  • About
    • Our Story
    • Our Focus
    • Our Team
    • Board of Directors
  • Our Science
    • Our Approach
    • Pipeline
    • Oxylanthanum Carbonate (OLC)
    • UNI-494
    • Publications & Press
  • Investors
  • Contact
    • Get in Touch
    • Careers

News & insights

  • Oxylanthanum carbonate (OLC), Videos

    Video: Interview with Dr. Glenn Chertow

    2/4/2025
    Read More: Video: Interview with Dr. Glenn Chertow
  • Oxylanthanum carbonate (OLC), Videos

    Video: Our Lead Asset (Oxylanthanum Carbonate)

    12/6/2024
    Read More: Video: Our Lead Asset (Oxylanthanum Carbonate)
  • Oxylanthanum carbonate (OLC), Peer Reviewed Publications

    AJN: High Phosphate-Binding Capacity of oxylanthanum carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate Binders

    11/30/2024
    Read More: AJN: High Phosphate-Binding Capacity of oxylanthanum carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate Binders
  • Oxylanthanum carbonate (OLC), Videos

    Video: Interview with Dr. Glenn Chertow

    2/4/2025
    Read More: Video: Interview with Dr. Glenn Chertow
  • Oxylanthanum carbonate (OLC), Peer Reviewed Publications

    AJN: High Phosphate-Binding Capacity of oxylanthanum carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate Binders

    11/30/2024
    Read More: AJN: High Phosphate-Binding Capacity of oxylanthanum carbonate with a Low Medication Volume: Comparison with Commercially Available Phosphate Binders


References
1. Centers for Disease Control and Prevention. Chronic Kidney Disease in the United States, 2023. Atlanta, GA: US Department of Health and Human Services, Centers for Disease Control and Prevention; 2023.

Unicycive Theraputics, Inc

About
Our story
Our focus
Our team
Boards of Directors

Our Science
Our Approach
Therapeutic Pipeline
OLC
UNI-494
Publications & Press

Investors

Contact
Careers

4300 El Camino Real, Suite #210 
Los Altos, CA 94022
+1 (650) 351-4495
info@unicycive.com

  • LinkedIn
  • YouTube
  • Facebook
  • Instagram
  • Twitter

Copyright © 2025 Unicycive

Legal Notices and Terms of Use Privacy Policy Ad and Cookie Policy